XML 74 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 62,820 $ 112,517
Marketable securities (Notes 3 and 15) 12,192 494
Trade and other receivables, net of allowance for credit losses of $223 and $223 as of December 31, 2022 and 2021, respectively 519 3,954
Inventories (Note 5) 38,155 30,772
Prepaid expenses and other current assets 9,529 1,568
Property, plant and equipment and other assets held for sale, net (Note 7) 12,375 0
Total current assets 135,590 149,305
Other long-term receivables 1,537 0
Inventories (Note 5) 2,465 1,368
Operating lease right of use asset 1,376 408
Investments accounted for at fair value (Note 6) 19,329 38,538
Property, plant and equipment, net (Note 7) 12,662 21,983
Mineral properties (Note 7) 83,539 83,539
Restricted cash (Note 8) 17,449 20,305
Total assets 273,947 315,446
Current liabilities    
Accounts payable and accrued liabilities (Note 13) 6,929 5,764
Operating lease liability 59 324
Deposits for assets held for sale 6,000 0
Asset retirement obligation and other liabilities held for sale (Note 8) 5,636 27
Total current liabilities 18,624 6,115
Operating lease liability 1,319 145
Asset retirement obligation (Note 8) 9,595 13,660
Total liabilities 29,538 19,920
Equity    
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 157,682,531 and 156,262,199 as of December 31, 2022 and 2021, respectively 698,493 685,903
Accumulated deficit (456,120) (396,271)
Accumulated other comprehensive income (loss) (1,946) 1,943
Total shareholders' equity 240,427 291,575
Non-controlling interests 3,982 3,951
Total equity 244,409 295,526
Total liabilities and equity 273,947 315,446
Commitments and contingencies (Note 14)